Market Access and User Adoption vary widely between Japan, Germany and the US

It is widely accepted that new technologies are responsible for both rising healthcare (HC) costs as well as for improved clinical outcomes. Research shows that there are substantial differences in how new products and techniques gain access to different markets, such as those in the US, Germany and Japan.

Read more